drugset / Trial / NCT00862472
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to demonstrate that the IOP-lowering efficacy of DuoTrav APS, dosed once-daily in the morning, is non-inferior to that of DuoTrav, dosed once-daily in the morning.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DuoTrav | Unknown | — | — |
| Subject | DuoTrav APS | Unknown | — | — |